BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sultana C, Oprişan G, Teleman MD, Dinu S, HepGen 88/2012 Project Team, Oprea C, Voiculescu M, Ruta S. Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C. World J Gastroenterol 2016; 22(37): 8406-8413 [PMID: 27729747 DOI: 10.3748/wjg.v22.i37.8406]
URL: https://www.wjgnet.com/1948-5182/full/v22/i37/8406.htm
Number Citing Articles
1
V. S. Kichatova, K. K. Kyuregyan, N. V. Soboleva, A. A. Karlsen, O. V. Isaeva, M. G. Isaguliants, M. I. Mikhailov. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic ContextJournal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7685371
2
Dan Yan Zhu, Xiao Zhao Deng, Yu Meng Zhu, Guo Tao Li, Guo Qiang Zhang, Ling Ju Wang, Jing Hai Zhang, Wen Xiao, Zhen Xian Zhou, Wei Liang Ding. Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis CArchives of Virology 2018; 163(5): 1253 doi: 10.1007/s00705-018-3750-9
3
Sorin Dinu, Grațiela Țârdei, Emanoil Ceaușu, Simin Aysel Florescu, Laurențiu Micu, Alina Monica Ecobici, Mariana Mihăilă, Gabriela Oprișan. Detection of anti-protease inhibitors resistance mutations in HCV strains infecting treatment-naïve chronic patients from RomaniaRevista Romana de Medicina de Laborator 2018; 26(4): 443 doi: 10.2478/rrlm-2018-0029
4
Aristodemos-Theodoros Periferakis, Argyrios Periferakis, Konstantinos Periferakis, Ana Caruntu, Ioana Anca Badarau, Ilinca Savulescu-Fiedler, Cristian Scheau, Constantin Caruntu. Antimicrobial Properties of Capsaicin: Available Data and Future Research PerspectivesNutrients 2023; 15(19): 4097 doi: 10.3390/nu15194097
5
Tayebeh Hashempour, Behzad Dehghani, Zahra Musavi, Javad Moayedi, Zahra Hasanshahi, Jamal Sarvari, Seyed Younes Hosseini, Ebrahim Hosseini, Maryam Moeini, Shahin Merat. Impact of IL28 Genotypes and Modeling the Interactions of HCV Core Protein on Treatment of Hepatitis CInterdisciplinary Sciences: Computational Life Sciences 2020; 12(4): 424 doi: 10.1007/s12539-020-00382-8
6
Diana Asema Asandem, Selorm Philip Segbefia, Kwadwo Asamoah Kusi, Joseph Humphrey Kofi Bonney. Hepatitis B Virus Infection: A Mini ReviewViruses 2024; 16(5): 724 doi: 10.3390/v16050724
7
Letícia Bomfim Campos, Nathália Alves Araújo de Almeida, Catarina Góis de Santana, Evorah Nascimento Pereira Barbosa, Marco Aurelio Pereira Horta, Márcia Amendola Pires, Carlos Eduardo Brandão Mello, Vanessa Salete de Paula, José Júnior França de Barros. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBVViruses 2023; 15(1): 187 doi: 10.3390/v15010187
8
Nikola Kokanov, Snezana Jovanovic-Cupic, Marina Siljic, Valentina Cirkovic, Nina Petrovic, Bojana Kozik, Milena Krajnovic. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from SerbiaArchives of Biological Sciences 2023; 75(3): 251 doi: 10.2298/ABS230316020K